Opportunity Information: Apply for RFA AT 18 001
The Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment - SAMHSA Opioid STR Grants (R21/R33) funding opportunity (RFA-AT-18-001) is a discretionary NIH grant designed to support research on how behavioral interventions perform when implemented alongside state efforts funded through SAMHSA's Opioid State Targeted Response (STR) program, which was authorized under the 21st Century Cures Act. The central aim is to generate evidence about whether specific behavioral approaches can prevent opioid use disorder (OUD) before it develops (primary prevention), reduce risk or progression among people already showing signs of misuse or early disorder (secondary prevention), or improve outcomes when used as an add-on to medication assisted treatment (MAT) for people diagnosed with OUD. In practical terms, this opportunity is trying to connect research directly to real-world, state-level opioid response plans rather than studying interventions in isolation.
The FOA explicitly encourages applications that test behavioral interventions such as mindfulness meditation, cognitive behavioral therapy (CBT), and multi-disciplinary rehabilitation. These interventions can be studied either as stand-alone prevention strategies or as adjunctive components layered onto MAT, which typically involves FDA-approved medications (for example, buprenorphine, methadone, or naltrexone) combined with counseling and recovery supports. A strong thematic priority is the overlap between OUD and chronic pain. Applications that focus on treating the comorbidity of opioid use disorder and chronic pain are described as being of particular interest, reflecting the clinical reality that pain and opioid exposure are often intertwined and that better pain management strategies may reduce relapse risk and improve overall functioning for people in treatment.
This opportunity uses the R21/R33 mechanism, which generally supports a phased approach: an initial exploratory or developmental phase (R21) followed by an expanded phase (R33) that can continue the project if predefined milestones are met. That structure is meant to help applicants move from early testing and feasibility work into more rigorous evaluation without having to start over with a completely separate award, while still holding projects accountable to concrete progress benchmarks. The funding activity category is health, and the CFDA number associated with this opportunity is 93.213.
Eligibility is broad and includes multiple levels of U.S. government and many types of organizations. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments); public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education under those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
At the same time, the FOA places clear restrictions on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components, as defined in the NIH Grants Policy Statement, are not allowed. This means the work is intended to be led and conducted within eligible U.S. organizational structures without formal foreign components.
Key administrative details from the source record include an original closing date of 2017-08-04 and a creation date of 2017-05-17. The award ceiling listed is $200,000, and while the expected number of awards is not specified in the provided data, the ceiling indicates the maximum award amount anticipated under the opportunity as summarized in the record. Overall, the grant is geared toward applied, policy-relevant research that tests behavioral strategies in the context of state STR implementation, with a notable emphasis on improving prevention and treatment outcomes for OUD, especially when chronic pain is part of the clinical picture.Apply for RFA AT 18 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
- This funding opportunity was created on 2017-05-17.
- Applicants must submit their applications by 2017-08-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is an NIH discretionary grant opportunity titled Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment - SAMHSA Opioid STR Grants (R21/R33), Funding Opportunity Announcement (FOA) RFA-AT-18-001.
What is the main purpose of the grant?
The purpose is to generate evidence on how behavioral interventions perform when implemented in real-world settings alongside state efforts funded through SAMHSA's Opioid State Targeted Response (STR) program (authorized under the 21st Century Cures Act). The FOA emphasizes connecting research directly to state-level opioid response plans rather than studying interventions in isolation.
What kinds of research does this FOA support?
The FOA supports research that evaluates behavioral interventions for:
- Primary prevention: preventing opioid use disorder (OUD) before it develops
- Secondary prevention: reducing risk or slowing progression among people showing signs of misuse or early disorder
- Adjunct to treatment: improving outcomes when used as an add-on to medication assisted treatment (MAT) for individuals diagnosed with OUD
What behavioral interventions are encouraged?
Applications are explicitly encouraged to test behavioral interventions such as:
- Mindfulness meditation
- Cognitive behavioral therapy (CBT)
- Multi-disciplinary rehabilitation
These may be studied as stand-alone prevention strategies or as adjunctive components layered onto MAT.
How does this grant relate to Medication Assisted Treatment (MAT)?
The FOA allows behavioral interventions to be evaluated as an add-on to MAT, which typically includes FDA-approved medications (for example, buprenorphine, methadone, or naltrexone) along with counseling and recovery supports.
Is there a special focus area mentioned in the FOA?
Yes. A strong thematic priority is the overlap between opioid use disorder (OUD) and chronic pain. Applications focused on treating comorbidity of OUD and chronic pain are described as being of particular interest.
Why is chronic pain emphasized?
The FOA highlights the clinical reality that pain and opioid exposure are often intertwined. It suggests that improved pain management strategies may reduce relapse risk and improve overall functioning for people in treatment.
What funding mechanism is used (R21/R33), and what does it mean?
This FOA uses the R21/R33 mechanism, which is generally a phased approach:
- R21 phase: an exploratory/developmental phase (often focused on early testing and feasibility)
- R33 phase: an expanded phase that can continue the project if predefined milestones are met
The structure is intended to support progression from feasibility work into more rigorous evaluation without requiring a separate, entirely new award, while still requiring concrete milestone-based progress.
What are the milestone requirements for moving from R21 to R33?
The FOA indicates that continuation from the R21 phase to the R33 phase depends on meeting predefined milestones. Specific milestone details are not provided in the information shown here, but the mechanism is described as being accountable to concrete progress benchmarks.
What is the funding activity category?
The funding activity category is health.
What CFDA number is associated with this opportunity?
The CFDA number associated with this opportunity is 93.213.
Who is eligible to apply?
Eligibility is broad and includes many U.S. government entities and organization types, including:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Native American tribal governments (federally recognized)
- Tribal organizations (including those other than federally recognized tribal governments)
- Public housing authorities and Indian housing authorities
- Nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education under those nonprofit categories)
- For-profit organizations other than small businesses
- Small businesses
Are any specific institution types highlighted as eligible?
Yes. The FOA highlights additional eligible applicant types, including:
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Faith-based or community-based organizations
- Regional organizations
- Eligible federal agencies
- U.S. territories or possessions
Are foreign organizations eligible to apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.
Can a U.S. organization include a foreign component or non-domestic component?
No. The FOA places clear restrictions stating that non-domestic components of U.S. organizations are not eligible, and foreign components (as defined in the NIH Grants Policy Statement) are not allowed.
What is the award ceiling for this opportunity?
The award ceiling listed in the source record is $200,000.
How many awards will be made?
The expected number of awards is not specified in the provided information.
What is the original closing date?
The original closing date listed is 2017-08-04.
What is the creation date of the opportunity record?
The creation date listed is 2017-05-17.
What makes this FOA different from studying interventions in a controlled research setting?
Based on the description provided, the FOA is designed to connect research to real-world implementation by studying behavioral interventions in the context of state STR program efforts, rather than evaluating interventions in isolation from state-level opioid response plans.
Is the grant limited only to prevention, or can it include treatment improvement as well?
It includes both. The FOA supports prevention research (primary and secondary prevention) and also supports research on behavioral interventions as an adjunct to MAT to improve outcomes for people diagnosed with OUD.
Browse more opportunities from the same category: Health
Next opportunity: Development of a Device to Objectively Measure Pain (R41/R42)
Previous opportunity: Fostering Research Training and Education Programs for Native American Students at NCI-designated Cancer Centers (Admin Supp)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AT 18 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AT 18 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) Apply for PAR 17 293 Funding Number: PAR 17 293 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (X01) Apply for RFA HL 18 009 Funding Number: RFA HL 18 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01) Apply for PA 17 291 Funding Number: PA 17 291 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R21) Apply for PA 17 292 Funding Number: PA 17 292 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01) Apply for PAR 17 294 Funding Number: PAR 17 294 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Stakeholder Consultative Workshop in Guatemala Apply for NEWHEALTHACTIVITY Funding Number: NEWHEALTHACTIVITY Agency: Guatemala USAID-Guatemala City Category: Health Funding Amount: Case Dependent |
| Alcohol-Induced Effects on Tissue Injury and Repair (R01) Apply for PA 17 297 Funding Number: PA 17 297 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32) Apply for RFA HS 17 011 Funding Number: RFA HS 17 011 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Alcohol-Induced Effects on Tissue Injury and Repair (R21) Apply for PA 17 296 Funding Number: PA 17 296 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 18 015 Funding Number: RFA AG 18 015 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Socioeconomic Disparities in Health and Mortality at Older Ages (R01) Apply for RFA AG 18 011 Funding Number: RFA AG 18 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Partnerships for the Development of Vaccines and Immunophrophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01) Apply for RFA AI 17 017 Funding Number: RFA AI 17 017 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Partnerships for Development of Clinically Useful Diagnostics for Antimicrobial-Resistant Bacteria (R01) Apply for RFA AI 17 014 Funding Number: RFA AI 17 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03) Apply for PAR 17 301 Funding Number: PAR 17 301 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| NeuroNEXT Small Business Innovation in Clinical Trials (U44) Apply for PAR 17 300 Funding Number: PAR 17 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21) Apply for PA 17 306 Funding Number: PA 17 306 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54) Apply for PAR 17 304 Funding Number: PAR 17 304 Agency: National Institutes of Health Category: Health Funding Amount: $4,000,000 |
| Grants to Support the Historically Black Colleges and Universities Health Services Research Grant Program Apply for CMS 1I0 17 001 Funding Number: CMS 1I0 17 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $325,000 |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 17 001 Funding Number: CMS 1H0 17 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $325,000 |
| NINDS Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25) Apply for PAR 17 312 Funding Number: PAR 17 312 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 18 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
